Anterix INC Form 4 insider transactions

Anterix Inc.'s Chief Financial Officer, Timothy Gray, purchased 50 shares of common stock at $22.07 per share.

Anterix Inc. director and 10% owner Jeffrey A. Altman reported an acquisition of restricted stock as compensation, aligning his interests with shareholders.

Anterix Inc. Director and 10% owner William Heard was granted 7,767 shares of common stock as compensation for his board service.

Anterix Inc. director Mahvash Yazdi was granted 7,767 shares of restricted common stock as compensation for her service.

Anterix Inc. Director Leslie Daniels was granted 7,767 shares of restricted common stock as compensation for his service.

Anterix Inc. Director Mark Fleischhauer was granted 7,767 shares of restricted common stock as compensation, vesting by August 2026.

Anterix Inc.'s Chief Operating Officer, Ryan Gerbrandt, disposed of 1,470 shares of common stock at $23.95 per share to cover tax withholding obligations related to restricted stock unit vesting.

Anterix Inc. Chief Regulatory & Communications Officer, Christopher Guttman-McCabe, disposed of 1,517 shares of common stock at $23.95 per share to cover tax withholding obligations related to restricted stock unit vesting.

Anterix Inc. Executive Chairman Thomas R. Kuhn was granted 6,222 restricted stock units, increasing his total beneficial ownership to 16,594 shares.

Anterix Inc.'s Chief Legal Officer and Corporate Secretary, Gena L. Ashe, reported the disposition of 2,732 shares of common stock to satisfy tax withholding obligations related to the partial vesting of restricted stock units.

Anterix Inc. President and CEO Scott A. Lang was granted 223,546 stock options with an exercise price of $34.96, vesting over three years.

An SEC Form 4 filing reveals Anterix Inc.'s Chief Financial Officer, Timothy Gray, disposed of 4,098 shares of common stock on May 22, 2025, to cover tax withholding obligations related to restricted stock unit vesting.

Christopher Guttman-McCabe, Chief Regulatory & Communications Officer of Anterix Inc., reports the acquisition of stock options.

Anterix Inc.'s Chief Financial Officer, Timothy Gray, was granted stock options to purchase 53,491 shares of common stock.

Ryan Gerbrandt, Chief Operating Officer of Anterix Inc., reports the acquisition of stock options.

Gena L. Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., reports the acquisition of stock options.

Christopher Guttman-McCabe, Chief Reg & Comm Officer of Anterix Inc., reports the withholding of shares by the issuer to cover withholding obligations related to the vesting and settlement of restricted stock units.

Anterix's Chief Financial Officer, Timothy Gray, disposed of shares to cover withholding obligations related to the vesting of restricted stock units.

Ryan Gerbrandt, Chief Operating Officer of Anterix Inc., disposed of shares to cover withholding tax obligations related to the vesting of restricted stock units.

Gena L. Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., disposed of shares to cover withholding obligations related to the vesting of restricted stock units.

Director William Heard reports multiple disposals of Anterix Inc. common stock through Heard Capital LLC between February and March 2025.

Director William Heard reports acquisition of 1,887 shares of Anterix Inc. common stock and indirect ownership of 1,741,989 shares through Heard Capital LLC.

An amended SEC Form 4 filing reveals a correction to the expiration date of stock options granted to Anterix Inc.'s President and CEO, Scott A. Lang.

Thomas R. Kuhn, a director and Chairman of Anterix Inc., reports the acquisition of stock options exercisable for 56,803 shares of common stock.

Anterix CEO Scott Lang was granted 191,326 stock options on January 17, 2025, which vest over three years.

Anterix Inc.'s Chief Regulatory and Communications Officer, Christopher Guttman-McCabe, was granted stock options for 67,774 shares on January 16, 2025.

Anterix Inc.'s Chief Legal Officer, Gena L. Ashe, was granted stock options for 37,275 shares, vesting over three years starting January 16, 2025.

Anterix's Chief Financial Officer, Timothy Gray, was granted 40,664 stock options on January 16, 2025, which vest over three years.

Anterix Inc.'s Chief Operating Officer, Ryan Gerbrandt, was granted stock options for 67,774 shares, vesting over three years starting January 16, 2025.

Anterix Inc. filed an amended Form 4 to correct a previously reported stock option grant to director Thomas R. Kuhn, reducing it from 61,804 to 7,108 shares.